Bandingkan kaedah

	Docking Molekular	Pemodelan Homologi	QSAR
Bidang	Bioinformatik	Bioinformatik	Bioinformatik
Keluarga	Process / pipeline	Process / pipeline	Process / pipeline
Tahun asal	1982	1993	1964
Pengasas	Irwin Kuntz	Andrej Sali	Corwin Hansch
Jenis	Binding prediction pipeline	Comparative structure prediction pipeline	Regression-based predictive modeling pipeline
Sumber perintis	Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology, 161(2), 269-288.	Sali, A. & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779-815.	Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626.
Alias	protein-ligand docking, binding prediction	comparative modeling, template-based modeling	QSAR model, quantitative structure-activity relationship
Berkaitan	4	4	3
Ringkasan	Molecular docking predicts the preferred binding orientation and affinity of a ligand (small molecule) within a protein binding pocket. Pioneered by Kuntz and colleagues in 1982, this computational method searches conformational space to find energetically favorable ligand-protein complexes, enabling rapid screening of chemical libraries for drug discovery.	Homology modeling, also called comparative modeling, predicts the three-dimensional structure of a protein using an experimentally-solved structure of a homologous protein as a template. Introduced by Sali and Blundell in 1993, this method exploits the principle that homologous proteins share similar spatial structures despite differing in amino acid sequence.	Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization.